Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Cash (2019 - 2025)

Historic Change in Cash for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $18.1 million.

  • Legend Biotech's Change in Cash fell 9295.74% to $18.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$178.1 million, marking a year-over-year increase of 6477.6%. This contributed to the annual value of -$988.9 million for FY2024, which is 30140.1% down from last year.
  • Per Legend Biotech's latest filing, its Change in Cash stood at $18.1 million for Q3 2025, which was down 9295.74% from -$179.6 million recorded in Q2 2025.
  • Legend Biotech's Change in Cash's 5-year high stood at $570.8 million during Q2 2023, with a 5-year trough of -$696.3 million in Q2 2024.
  • In the last 5 years, Legend Biotech's Change in Cash had a median value of -$25.6 million in 2022 and averaged -$9.1 million.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 61155.27% in 2022, then surged by 1989989.49% in 2023.
  • Quarter analysis of 5 years shows Legend Biotech's Change in Cash stood at $350.5 million in 2021, then crashed by 107.3% to -$25.6 million in 2022, then soared by 1322.17% to $312.8 million in 2023, then tumbled by 154.43% to -$170.3 million in 2024, then soared by 110.66% to $18.1 million in 2025.
  • Its last three reported values are $18.1 million in Q3 2025, -$179.6 million for Q2 2025, and $153.6 million during Q1 2025.